|
C9ORF102 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.15270015754732E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.99329483211386E-11 |
| Normal-vs-Stage2 |
4.12430000151787E-08 |
| Normal-vs-Stage3 |
1.98463467881993E-12 |
| Normal-vs-Stage4 |
1.65523150741365E-12 |
| Stage1-vs-Stage2 |
8.304600E-01 |
| Stage1-vs-Stage3 |
1.133010E-01 |
| Stage1-vs-Stage4 |
1.160140E-03 |
| Stage2-vs-Stage3 |
1.879840E-01 |
| Stage2-vs-Stage4 |
2.445800E-02 |
| Stage3-vs-Stage4 |
1.328170E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.25169874465314E-11 |
| Normal-vs-AfricanAmerican |
5.98569999999965E-05 |
| Normal-vs-Asian |
4.77500261553132E-11 |
| Caucasian-vs-AfricanAmerican |
2.663600E-01 |
| Caucasian-vs-Asian |
4.759000E-01 |
| AfricanAmerican-vs-Asian |
1.487760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.23343565863843E-12 |
| Normal-vs-Female |
4.01260136229098E-11 |
| Male-vs-Female |
3.842000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.71739955590056E-10 |
| Normal-vs-Age(41-60Yrs) |
9.25681753471963E-12 |
| Normal-vs-Age(61-80Yrs) |
5.56155121955726E-12 |
| Normal-vs-Age(81-100Yrs) |
6.814000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.474000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.574780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.254800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.707600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.944000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.118800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.204900E-03 |
| Classical-VS-Follicular |
3.894000E-01 |
| Classical-VS-Other |
1.334650E-01 |
| Classical-VS-Normal |
2.11059947297088E-10 |
| Tall-VS-Follicular |
1.005800E-01 |
| Tall-VS-Other |
6.212800E-01 |
| Tall-VS-Normal |
1.94311233769895E-12 |
| Follicular-VS-Other |
2.871200E-01 |
| Follicular-VS-Normal |
1.09949827020728E-11 |
| Other-VS-Normal |
9.28509999997829E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.28800303755838E-11 |
| Normal-vs-N1 |
1.07810427252275E-11 |
| N0-vs-N1 |
2.509400E-01 |
|
|
